Physician profile
Roger Moon
NPI 1881952828
$11,113.60
in general payments reported to CMS, 2019-2025
35 companies · $1,149 in 2025
The $1,149 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,733 · 2020: $811 · 2021: $630 · 2022: $723 · 2023: $1,382 · 2024: $1,685 · 2025: $1,149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,216.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,912.97 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Medtronic USA, INC. | $3,488.34 | 2019-2020 | |
| Daiichi Sankyo INC. | $471.68 | 2019 | |
| Abbott Laboratories | $459.97 | 2019-2023 | Proclaim |
| Si-Bone, INC. | $342.35 | 2025 | |
| Boston Scientific Corporation | $331.38 | 2019-2024 | |
| Nevro Corp. | $324.69 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $250.75 | 2019-2024 | |
| Saluda Medical Americas, INC. | $226.14 | 2023 | Evoke Scs |
| Tersera Therapeutics LLC | $211.61 | 2019-2024 | Prialt |
| Zynex Medical, INC. | $153.16 | 2023 | Nexwave |
| Averitas Pharma INC. | $137.43 | 2023-2024 | Qutenza |
| Vertiflex, INC. | $123.83 | 2019 | |
| West Therapeutics Development, LLC | $85.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.49 | 2020-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $48.36 | 2020-2021 | |
| Biotronik Nro, INC. | $39.92 | 2025 | Prospera |
| Arbor Pharmaceuticals, INC. | $39.36 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $38.29 | 2020 | |
| Redhill Biopharma INC. | $35.36 | 2020 | |
| Pfizer INC. | $33.24 | 2019 | |
| Micromed INC | $32.90 | 2021 | |
| Assertio Therapeutics, INC. | $28.32 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.74 | 2022-2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $24.98 | 2025 | |
| Azurity Pharmaceuticals, INC. | $23.37 | 2024 | Horizant |
| Horizon Therapeutics Plc | $23.11 | 2019 | |
| Valinor Pharma, LLC | $21.32 | 2023 | Movantik |
| Medline Industries LP | $20.37 | 2025 | |
| Biotissue Holdings INC. | $17.89 | 2024 | |
| Ibsa Pharma INC. | $17.62 | 2023 | Tirosint, Licart |
| Zyla Life Sciences, INC. | $16.34 | 2019 | |
| Avanos Medical | $13.17 | 2019 | |
| Almatica Pharma LLC | $12.49 | 2021 | |
| Spr Therapeutics, INC | $10.35 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.